Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND01, which is in Phase II clinical trials for use in the treatment of depression; BMND08, a 5-Metoxi-N,N-dimethyltryptamine sublingual formulation that is in Phase II clinical trials for treatment of depression and anxiety in patients with Alzheimer's disease; BMND06 is in Ph...
Industry: Biotechnology
Sector: Healthcare
Address:
515 – 701 W. Georgia Street, Camino Saravia s/n 91.000, Pando, Vancouver, Canada
